Key result
SiteSeal closure device linked to better immediate hemostasis and fewer access complications vs. manual compression.
Why the study?
As sheath sizes increase for structural heart and vascular procedures, no dedicated closure devices overcome all challenges of vascular hemostasis, particularly for venous access where manual compression is strained.
Does the SiteSeal Vascular Closure Device improve hemostasis and reduce access site complications compared to manual compression in patients undergoing cardiovascular procedures?
Does the SiteSeal Vascular Closure Device improve hemostasis and reduce access site complications compared to manual compression in patients undergoing cardiovascular procedures?
The SiteSeal Vascular Closure Device offers a novel 'leave-nothing-behind' approach that may improve hemostasis efficacy and reduce complications compared to manual compression, particularly for large-bore access.
Should not yet change practice for vascular closure; leaves open need for randomized confirmation.
Vascular hemostasis after venous and arterial access in cardiovascular procedures remains a challenge. As sheath size gets larger for structural heart and vascular procedures, no dedicated closure devices exist that can overcome all the challenges of achieving vascular hemostasis, in particular on the venous side. Efficiently and reliably ensuring hemostasis at the access point is crucial for enhancing the safety of a procedure. Historically, hemostasis relied on manually compressing venous access sites. However, the shift towards larger sheaths and the more frequent use of continuous anticoagulation has strained this approach. Achieving hemostasis solely through compression in these scenarios demands heightened vigilance and prolonged application, resulting in increased patient discomfort and extended immobility. Consequently, manual compression may consume more time for healthcare providers and contribute to bed occupancy in hospitals. This review article summarizes the development of the SiteSeal® Vascular Closure Device, a novel leave-nothing-behind approach to achieve hemostasis. The introduction of this technology has provided clinicians with a safer and more effective way to achieve immediate hemostasis, facilitate early ambulation, and enable earlier discharges with fewer access site complications compared with traditional manual compression.
No takes yet. Share an insight, caveat, or question.
Yazdani et al. (2024) conducted a review in Vascular hemostasis after venous and arterial access. SiteSeal Vascular Closure Device vs. traditional manual compression was evaluated. The SiteSeal Vascular Closure Device provides a safer and more effective way to achieve immediate hemostasis and fewer access site complications compared with traditional manual compression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: